Írország - angol - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - cisplatin - concentrate for soln for inf - 0.5 micromol

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinflunine ditartrate 34.18 mg/ml equivalent to vinflunine 25 mg/ml - concentrate for injection - 25 mg/ml - active: vinflunine ditartrate 34.18 mg/ml equivalent to vinflunine 25 mg/ml excipient: nitrogen water for injection - javlor is indicated as monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - metoclopramide hydrochloride monohydrate 5 mg/ml - solution for injection - 5 mg/ml - active: metoclopramide hydrochloride monohydrate 5 mg/ml

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - oxaliplatin 5 mg/ml - solution for injection - 5 mg/ml - active: oxaliplatin 5 mg/ml excipient: water for injection - oxaliplatin, in combination with 5-fluorouracil and folinic acid, is indicated for: · adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour.

Írország - angol - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin

Írország - angol - HPRA (Health Products Regulatory Authority)

accord healthcare limited - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin

Málta - angol - Medicines Authority

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Málta - angol - Medicines Authority

actavis group h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml - concentrate for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml excipient: hydrochloric acid nitrogen sodium hydroxide sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with convention

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; nitrogen; sodium chloride - for use in the treatment of metastatic nonseminomatous germ cell carcinoma, advanced stage refractory ovarian carcinoma, advanced stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck, either singularly or in combination with other chemotherapeutic agents; or in appropriate circumstances, in addition to other treatments, such as radiotherapy or surgery.